Stockreport

Femasys Announces Third Quarter Financial Results for 2025

Femasys Inc.  (FEMY) 
PDF – FDA Approval to Advance Final FemBloc® Trial with Clear Pathway to Potentially Achieve U.S. FDA Approval – – $12 Million Financing Strengthens Balance Sheet and Ext [Read more]